We are live on ! Find out more
CIC

Chase Investment Counsel Portfolio holdings

AUM $474M
1-Year Est. Return 95.11%
This Fund
S&P 500
This Quarter Est. Return
+6.86%
1 Year Est. Return
+95.11%
3 Year Est. Return
+349.64%
5 Year Est. Return
+621.11%
10 Year Est. Return
+3,935.08%
AUM
$186M
AUM Growth
-$6.7M
Cap. Flow
-$17.5M
Cap. Flow %
-9.41%
Top 10 Hldgs %
35.58%
Holding
100
New
13
Increased
24
Reduced
45
Closed
13

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$3.37M
2
FANG icon
Diamondback Energy
FANG
+$2.78M
3
PVH icon
PVH
PVH
+$2.09M
4
CAF
Morgan Stanley China A Share Fund
CAF
+$1.15M
5
USFD icon
US Foods
USFD
+$962K

Top Sells

Rank Stock Value
1
MAS icon
Masco
MAS
+$4.04M
2
LHX icon
L3Harris
LHX
+$3.73M
3
RTN
Raytheon Company
RTN
+$3.54M
4
MS icon
Morgan Stanley
MS
+$3.07M
5
SBUX icon
Starbucks
SBUX
+$2.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.98%
2 Technology 16.35%
3 Healthcare 14.27%
4 Financials 13.95%
5 Industrials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CY
51
DELISTED
Cypress Semiconductor
CY
$794K 0.43%
51,024
+20,104
+65% +$331K
SNV
52
DELISTED
Synovus
SNV
$766K 0.41%
+14,515
New +$772K
PLNT icon
53
Planet Fitness
PLNT
$3.7B
$741K 0.4%
16,875
-540
-3% -$22.2K
AWI icon
54
Armstrong World Industries
AWI
$7.75B
$645K 0.35%
+10,210
New +$608K
ZWS icon
55
Zurn Elkay Water Solutions
ZWS
$8.47B
$637K 0.34%
+45,516
New +$643K
LPLA icon
56
LPL Financial
LPLA
$29.3B
$625K 0.34%
9,545
-170
-2% -$11.2K
NTAP icon
57
NetApp
NTAP
$39B
$594K 0.32%
7,574
-340
-4% -$23.9K
AVY icon
58
Avery Dennison
AVY
$13.5B
$556K 0.3%
5,450
-5,900
-52% -$624K
IART icon
59
Integra LifeSciences
IART
$1.33B
$549K 0.3%
8,525
-250
-3% -$15.5K
JAZZ icon
60
Jazz Pharmaceuticals
JAZZ
$16.7B
$543K 0.29%
3,155
-80
-2% -$13.1K
BLD
61
DELISTED
TopBuild
BLD
$538K 0.29%
+6,880
New +$553K
ENTG icon
62
Entegris
ENTG
$22B
$537K 0.29%
15,870
-810
-5% -$28.7K
NOVT icon
63
Novanta
NOVT
$6.2B
$527K 0.28%
8,475
-410
-5% -$25.1K
KEX icon
64
Kirby Corp
KEX
$7B
$390K 0.21%
+4,670
New +$405K
FNV icon
65
Franco-Nevada
FNV
$46.5B
$386K 0.21%
5,291
-124
-2% -$8.79K
IP icon
66
International Paper
IP
$21.9B
$321K 0.17%
6,509
+290
+5% +$14.8K
MRK icon
67
Merck
MRK
$323B
$313K 0.17%
5,419
+95
+2% +$5.36K
VZ icon
68
Verizon
VZ
$195B
$298K 0.16%
5,932
+247
+4% +$12K
LVS icon
69
Las Vegas Sands
LVS
$29.4B
$295K 0.16%
3,864
+94
+2% +$7.18K
SLB icon
70
SLB Ltd
SLB
$78.9B
$290K 0.16%
4,330
+75
+2% +$5.15K
CVX icon
71
Chevron
CVX
$382B
$269K 0.14%
2,129
+55
+3% +$6.83K
JNJ icon
72
Johnson & Johnson
JNJ
$631B
$262K 0.14%
2,160
PFE icon
73
Pfizer
PFE
$154B
$261K 0.14%
7,605
+1,212
+19% +$41.4K
PM icon
74
Philip Morris
PM
$290B
$249K 0.13%
3,094
+874
+39% +$74.2K
CVS icon
75
CVS Health
CVS
$122B
$248K 0.13%
3,860
+75
+2% +$4.94K

Similar funds

Chase Investment Counsel's Q2 2018 Portfolio in Review

As of Q2 2018, Chase Investment Counsel held 100 positions worth $186M, down 3.5% from $193M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Chase Investment Counsel withdrew a net $17.5M in Q2 2018, closing 13 positions and reducing 45 holdings. Its most notable exit was Masco, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Chase Investment Counsel opened a new position in Centene worth $3.6M.

  • Chase Investment Counsel's largest Q2 2018 buy was Centene: 58,514 shares worth $3.6M.
  • Chase Investment Counsel added most to PVH in Q2 2018, an estimated $2.09M increase.
  • Chase Investment Counsel's biggest Q2 2018 reduction was UnitedHealth, cutting an estimated $934K.
  • Chase Investment Counsel fully exited Masco in Q2 2018, selling an estimated $4.04M.
  • Chase Investment Counsel's ten largest holdings make up 36% of its $186M portfolio in Q2 2018.
  • Chase Investment Counsel opened 13 new positions and closed 13 in Q2 2018.
  • Chase Investment Counsel's portfolio value fell 3.5% quarter-over-quarter to $186M.

Based on Chase Investment Counsel's 13F filing for Q2 2018, filed 7 Aug 2018.